Menu

The latest from Magnitude Biosciences

A fully-fledged pre-clinical contract services provider. 
Here’s what we’ve been up to along the way!

24 March 2022
Ageing drug discovery biotech sees exciting early in vivo data for lead compound

Five Alarm Bio works with Magnitude Biosciences to develop therapeutics for age-related disease.

Read More
21 March 2022
Case Study: Measuring efficacy to slow ageing for drug discovery biotech Five Alarm Bio

Five Alarm Bio, a UK drug discovery startup focussing on the underlying mechanisms of ageing to develop therapeutics for age-related disease, works with Magnitude Biosciences to test their compound, FAB001, to test their hypothesis on the nature of ageing.

Read More
10 February 2022
Tiny Worms- Experiments Fast

David Weinkove, CEO of Magnitude Biosciences joins New Matter

Read More
31 January 2022
Magnitude Biosciences CEO David Weinkove appointed new Chair of British Society for Research on Ageing

The British Society for the Research on Ageing (BSRA) announces its new Chair, biology of ageing researcher and entrepreneur David Weinkove, Associate Professor at the Department of Biosciences, Durham University and CEO of Magnitude Biosciences Ltd.

Read More
18 November 2021
Case Study: Michelin & Magnitude Biosciences

Michelin, a Fortune 500 consumer good manufacturing company and the global leader in tyre manufacturing, works with Magnitude Biosciences for a sustainable, ethical solution for whole organism toxicity testing.

Read More
8 November 2021
ELRIG Drug Discovery 2021

Take a look at our Poster from ELRIG Drug Discovery 2021: Automated Monitoring of C. elegans Movement for Neurodegeneration and Ageing.

Read More
No Post Added!
No Post Added!

CONTACT US

Get in touch today to find out how we can 
support you to accelerate your research

CONTACT US

Get in touch today to find out how we can 
support you to accelerate your research
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram